BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19341065)

  • 1. The living donor advocate: a team approach to educate, evaluate, and manage donors across the continuum.
    Rudow DL
    Prog Transplant; 2009 Mar; 19(1):64-70. PubMed ID: 19341065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the independent donor advocacy team in ethical decision making.
    Rudow DL; Brown RS
    Prog Transplant; 2005 Sep; 15(3):298-302. PubMed ID: 16252640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychosocial and Independent Living Donor Advocate Evaluation and Post-surgery Care of Living Donors.
    Rudow DL; Swartz K; Phillips C; Hollenberger J; Smith T; Steel JL
    J Clin Psychol Med Settings; 2015 Sep; 22(2-3):136-49. PubMed ID: 26293351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Independent Living Donor Advocate: An Essential Role for Living Kidney Donation.
    Robbins KC
    Nephrol Nurs J; 2014; 41(6):569-73, 586; quiz 574. PubMed ID: 26287054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent donor ethical assessment: aiming to standardize donor advocacy.
    Choudhury D; Jotterand F; Casenave G; Smith-Morris C;
    Prog Transplant; 2014 Jun; 24(2):163-8. PubMed ID: 24919733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidisciplinary program to educate and advocate for living donors.
    Sites AK; Freeman JR; Harper MR; Waters DB; Pruett TL
    Prog Transplant; 2008 Dec; 18(4):284-9. PubMed ID: 19186581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living kidney donor advocacy program: a quality improvement project.
    Bosek MS; Sargeant IL
    JONAS Healthc Law Ethics Regul; 2012; 14(1):19-26; quiz 27-8. PubMed ID: 22367016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor advocacy with special reference to Belgium.
    Squifflet JP
    Transplant Proc; 2011 Nov; 43(9):3392-5. PubMed ID: 22099804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the independent donor advocacy team in the case of a declined living donor candidate.
    Jennings T; Grauer D; Rudow DL
    Prog Transplant; 2013 Jun; 23(2):132-6. PubMed ID: 23782660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate, dedicated care teams for living organ donors.
    McQuarrie B; Gordon D
    Prog Transplant; 2003 Jun; 13(2):90-3. PubMed ID: 12841513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent living donor advocate: a guidance document from the American Society of Transplantation's Living Donor Community of Practice (AST LDCOP).
    Hays RE; LaPointe Rudow D; Dew MA; Taler SJ; Spicer H; Mandelbrot DA
    Am J Transplant; 2015 Feb; 15(2):518-25. PubMed ID: 25612499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal parent donors-Process and ethics.
    Filler G; de Ferris MED; Elliott L
    Pediatr Transplant; 2021 Aug; 25(5):e14062. PubMed ID: 34076958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical dimensions of living donation: experience with living liver donation.
    Miller CM
    Transplant Rev (Orlando); 2008 Jul; 22(3):206-9. PubMed ID: 18631880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Organ Donation.
    Tuttle-Newhall JE; Schnitzler M
    Mo Med; 2015; 112(3):151-7. PubMed ID: 26168580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Being Sherlock Holmes: the Internet as a tool for assessing live organ donors.
    Bramstedt KA; Katznelson S
    Clin Transplant; 2009; 23(2):157-61. PubMed ID: 19210684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living kidney donor informed consent practices vary between US and non-US centers.
    Parekh AM; Gordon EJ; Garg AX; Waterman AD; Kulkarni S; Parikh CR
    Nephrol Dial Transplant; 2008 Oct; 23(10):3316-24. PubMed ID: 18599559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ethics of Organ Donation in Patients Who Lack the Capacity for Decision Making.
    Lee L
    Creat Nurs; 2018 Aug; 24(3):186-190. PubMed ID: 30567762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Donor-Centered Approach to Risk Assessment: Rebalancing Nonmaleficence and Autonomy.
    Thiessen C; Gordon EJ; Reese PP; Kulkarni S
    Am J Transplant; 2015 Sep; 15(9):2314-23. PubMed ID: 25868787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The donor advocacy team: a risk management program for living organ, tissue, and cell transplant donors.
    Eguchi S; Soyama A; Nagai K; Miyazaki Y; Kurihara S; Hidaka M; Ono S; Adachi T; Natsuda K; Hara T; Fujita F; Kanetaka K; Takatsuki M
    Surg Today; 2017 Aug; 47(8):980-985. PubMed ID: 28205018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of a living donor liver transplantation advocacy program.
    Anderson-Shaw L; Schmidt ML; Elkin J; Chamberlin W; Benedetti E; Testa G
    J Clin Ethics; 2005; 16(1):46-57. PubMed ID: 15915845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.